(CPT) Camden Property Trust - Ratings and Ratios
Multifamily,Apartment,Communities,Leasing,Management
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 21.2% |
| Value at Risk 5%th | 34.7% |
| Relative Tail Risk | -0.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.64 |
| Alpha | -21.37 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.433 |
| Beta | 0.548 |
| Beta Downside | 0.717 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.55% |
| Mean DD | 11.59% |
| Median DD | 11.16% |
Description: CPT Camden Property Trust October 31, 2025
Camden Property Trust (NYSE:CPT) is an S&P 500-listed REIT focused on multifamily apartments. It currently owns and manages 173 properties with 59,046 units across the United States, and its development pipeline of four projects will raise the portfolio to 177 properties and roughly 60,600 homes once completed. The firm is also noted for its workplace culture, earning a spot on Fortune’s “100 Best Companies to Work For” for 18 straight years, most recently ranking #18.
Key operational metrics that analysts watch include an occupancy rate that hovered around 96% in FY 2023 and same-store rent growth of about 5% year-over-year, both above the industry median. The company’s balance sheet remains relatively strong, with a net debt-to-EBITDA ratio near 5.0×, giving it flexibility to fund its $1.2 billion development pipeline. Sector-wide, the multifamily market is being driven by sustained demand from millennials and Gen Z renters, limited new supply in high-growth metros, and a macro environment where rising interest rates have made home-ownership less affordable, bolstering rental demand.
If you want a deeper, data-rich view of CPT’s valuation dynamics, a quick look at ValueRay’s analyst toolkit can help you surface the most material assumptions and stress-test scenarios.
CPT Stock Overview
| Market Cap in USD | 10,923m |
| Sub-Industry | Multi-Family Residential REITs |
| IPO / Inception | 1993-07-22 |
| Return 12m vs S&P 500 | -23.1% |
| Analyst Rating | 3.68 of 5 |
CPT Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 4.09% |
| Yield on Cost 5y | 5.00% |
| Yield CAGR 5y | 5.55% |
| Payout Consistency | 96.2% |
| Payout Ratio | 3.3% |
CPT Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | -0.86% |
| CAGR/Max DD Calmar Ratio | -0.03 |
| CAGR/Mean DD Pain Ratio | -0.07 |
| Current Volume | 756.6k |
| Average Volume | 1300.5k |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (269.1m TTM) > 0 and > 6% of Revenue (6% = 94.1m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 3.57pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -55.64% (prev -26.91%; Δ -28.73pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 782.2m > Net Income 269.1m (YES >=105%, WARN >=100%) |
| Net Debt (-25.9m) to EBITDA (1.03b) ratio: -0.03 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.04 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (108.6m) change vs 12m ago 0.14% (target <= -2.0% for YES) |
| Gross Margin 61.28% (prev 61.35%; Δ -0.07pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 17.73% (prev 17.27%; Δ 0.46pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.07 (EBITDA TTM 1.03b / Interest Expense TTM 136.7m) >= 6 (WARN >= 3) |
Altman Z'' -0.95
| (A) -0.10 = (Total Current Assets 34.8m - Total Current Liabilities 907.8m) / Total Assets 8.75b |
| (B) -0.12 = Retained Earnings (Balance) -1.01b / Total Assets 8.75b |
| (C) 0.05 = EBIT TTM 419.4m / Avg Total Assets 8.85b |
| (D) -0.23 = Book Value of Equity -1.01b / Total Liabilities 4.44b |
| Total Rating: -0.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 67.75
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 4.83% = 2.42 |
| 3. FCF Margin 44.30% = 7.50 |
| 4. Debt/Equity 0.77 = 2.21 |
| 5. Debt/Ebitda -0.03 = 2.50 |
| 6. ROIC - WACC (= -1.31)% = -1.64 |
| 7. RoE 5.85% = 0.49 |
| 8. Rev. Trend 82.12% = 6.16 |
| 9. EPS Trend -47.82% = -2.39 |
What is the price of CPT shares?
Over the past week, the price has changed by -0.52%, over one month by -0.90%, over three months by -4.71% and over the past year by -12.64%.
Is CPT a buy, sell or hold?
- Strong Buy: 8
- Buy: 2
- Hold: 14
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CPT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 117.5 | 15.1% |
| Analysts Target Price | 117.5 | 15.1% |
| ValueRay Target Price | 104.7 | 2.5% |
CPT Fundamental Data Overview November 17, 2025
P/E Trailing = 41.5628
P/E Forward = 69.9301
P/S = 6.9199
P/B = 2.4078
P/EG = 8.96
Beta = 0.832
Revenue TTM = 1.57b USD
EBIT TTM = 419.4m USD
EBITDA TTM = 1.03b USD
Long Term Debt = 3.31b USD (from longTermDebt, last quarter)
Short Term Debt = 429.6m USD (from shortLongTermDebt, last quarter)
Debt = 3.49b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -25.9m USD (from netDebt column, last quarter)
Enterprise Value = 14.38b USD (10.92b + Debt 3.49b - CCE 25.9m)
Interest Coverage Ratio = 3.07 (Ebit TTM 419.4m / Interest Expense TTM 136.7m)
FCF Yield = 4.83% (FCF TTM 695.0m / Enterprise Value 14.38b)
FCF Margin = 44.30% (FCF TTM 695.0m / Revenue TTM 1.57b)
Net Margin = 17.15% (Net Income TTM 269.1m / Revenue TTM 1.57b)
Gross Margin = 61.28% ((Revenue TTM 1.57b - Cost of Revenue TTM 607.5m) / Revenue TTM)
Gross Margin QoQ = 60.69% (prev 61.16%)
Tobins Q-Ratio = 1.64 (Enterprise Value 14.38b / Total Assets 8.75b)
Interest Expense / Debt = 1.00% (Interest Expense 35.0m / Debt 3.49b)
Taxrate = 0.68% (780.0k / 114.4m)
NOPAT = 416.6m (EBIT 419.4m * (1 - 0.68%))
Current Ratio = 0.04 (Total Current Assets 34.8m / Total Current Liabilities 907.8m)
Debt / Equity = 0.77 (Debt 3.49b / totalStockholderEquity, last quarter 4.54b)
Debt / EBITDA = -0.03 (Net Debt -25.9m / EBITDA 1.03b)
Debt / FCF = -0.04 (Net Debt -25.9m / FCF TTM 695.0m)
Total Stockholder Equity = 4.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.07% (Net Income 269.1m / Total Assets 8.75b)
RoE = 5.85% (Net Income TTM 269.1m / Total Stockholder Equity 4.60b)
RoCE = 5.30% (EBIT 419.4m / Capital Employed (Equity 4.60b + L.T.Debt 3.31b))
RoIC = 5.02% (NOPAT 416.6m / Invested Capital 8.30b)
WACC = 6.33% (E(10.92b)/V(14.41b) * Re(8.03%) + D(3.49b)/V(14.41b) * Rd(1.00%) * (1-Tc(0.01)))
Discount Rate = 8.03% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.79%
[DCF Debug] Terminal Value 81.31% ; FCFE base≈573.5m ; Y1≈701.2m ; Y5≈1.17b
Fair Price DCF = 187.6 (DCF Value 19.96b / Shares Outstanding 106.4m; 5y FCF grow 23.81% → 3.0% )
EPS Correlation: -47.82 | EPS CAGR: -21.68% | SUE: -0.13 | # QB: 0
Revenue Correlation: 82.12 | Revenue CAGR: 1.88% | SUE: -1.54 | # QB: 0
Additional Sources for CPT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle